Work

MA15.11 A Phase I/II Study of TQ-B2450 plus Anlotinib in EGFR+ Advanced NSCLC Patients Failed to Prior EGFR TKI Therapies: Phase II Results Updates

Year: 2023

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2023.09.228

Authors: M. Shi, P. Chen, L. Cui, Y. Yao, J. Wang, T. Zhou, J. Feng

Institutions: Jiangsu Cancer Hospital, Wuhu No 1 People's Hospital, The No. 2 People's Hospital of Lanzhou, Zhangqiu City People's Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4388069600

FWCI:

Cites:

Cited by:

Related to: 10